The above-mentioned German breast cancer registry could even demonstrate, in a recent analysis, that compared to patients treated with CDK4/6i or an ET monotherapy, those under chemotherapy in the first line had the most unfavorable prognosis regarding both the PFS and the OS. Here, CDK4 is linked to breast carcinoma.